Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.35
-$0.44-55.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.14% | 137.16% | 67.75% | -55.82% | -42.33% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -44.93% | -73.65% | -57.21% | -36.45% | 262.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.86% | 98.42% | 49.52% | -53.64% | -38.05% |
|
|
|||||
| Total Current Assets | 2.86% | 98.42% | 49.52% | -53.64% | -38.05% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Assets | 2.71% | 87.85% | 44.48% | -47.56% | -34.59% |
|
|
|||||
| Total Accounts Payable | -52.11% | -38.12% | 5.87% | -17.47% | 63.24% |
| Total Accrued Expenses | -50.90% | -55.41% | -29.37% | -24.57% | -39.19% |
| Short-term Debt | -11.20% | -- | -45.45% | -32.44% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 47.04% | 107.14% | 27.95% | -- |
| Total Other Current Liabilities | -- | 47.04% | 107.14% | 27.95% | -- |
| Total Current Liabilities | -50.17% | -44.46% | -13.39% | -20.58% | -14.98% |
|
|
|||||
| Total Current Liabilities | -50.17% | -44.46% | -13.39% | -20.58% | -14.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -11.20% | -- | -45.45% | -32.44% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -42.88% | -88.88% | -92.07% | -88.97% |
| Total Liabilities | -50.47% | -44.45% | -14.19% | -22.27% | -18.30% |
|
|
|||||
| Common Stock & APIC | 16.78% | 25.19% | 22.77% | 18.37% | 17.86% |
| Retained Earnings | -12.09% | -14.40% | -18.12% | -20.40% | -22.27% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 964.19% | 145.58% | 92.40% | -231.40% | -85.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 964.19% | 145.58% | 92.40% | -231.40% | -85.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 964.19% | 145.58% | 92.40% | -231.40% | -85.79% |
|
|
|||||